Skip to Main Content
Transmittal #
R118CP
Subject
Frequency Limitations for Darbepoetin Alfa (trade name Aranesp) For Treatment Of Anemia In End Stage Renal Disease (ESRD) Patients On Dialysis.
Implementation Date
04/05/2004
CR #
2984
Publication #
100-04
MM Article #
N/A
MM Article Release Date
N/A
MM Article Revised Date
N/A
Related CR Release Date
N/A
Related CR Effective Date
N/A
Job Aid #
N/A